Improving Migraine Screening and Treatment in Black Female Patients: Addressing Gender and Racial Disparities in Migraine Car

Subject areas

This course counts toward the state boards and subject areas below.

Disclosure statements

Postgraduate Institute for Medicine (PIM) requires faculty, planners, and others in control of educational content to disclose all their financial relationships with ineligible companies. All identified conflicts of interest (COI) are thoroughly vetted and mitigated according to PIM policy. PIM is committed to providing its learners with high quality accredited continuing education activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

All relevant financial relationships have been mitigated.

The faculty reported the following relevant financial relationships with ineligible entities related to the educational content of this CE activity:

Dr. Cynthia E. Armand reports being a consultant for LinPharma and advisory board member for Pfizer.

Dr. Larry Charleston reports having received grant and research support from Amgen, being a consultant/advisory board member for Allergan/Abbvie, Amgen, Amneal, Aurene, Biohaven, Haleon, LinPharma, Mi-Helper Inc., Pfizer, and Satsuma, and reports having received non- mutual funds stock ownership or stock options as an advisory panel member for Mi-Helper Inc.

Hope O’Brien, MD, MBA, FAHS, FAAN

Dr. O’Brien reports have received Grant/Research Support from AbbVie and Lilly; Speakers Bureau/ Honoraria for non-CME from AbbVie, Lilly, Pfizer, and Scilex; Consultant/Advisory Board for AbbVie, Lilly, and Scilex; being up-to-date for editorial contributions; Honoraria from American Academy of Neurology

Planners and Managers

The PIM planners and managers have nothing to disclose. The CE Health Interactive planners and managers have nothing to disclose.

FEE INFORMATION

There is no fee for this educational activity.

INSTRUCTIONS FOR OBTAINING CREDIT

During the period of accreditation, participants must 1) read the learning objectives and disclosures; 2) study the educational content; and 3) complete the post-test (if applicable) and the evaluation form. To answer the questions, click on your selected choice for each answer and then proceed to the next question. If applicable, your post-test will automatically be graded. After successfully completing these items, your certificate will be made available immediately. Click on View Certificate, and print or download the certificate for your records.

DISCLOSURE OF UNLABELED USE

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

DISCLAIMER

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medicat